Aehr Test Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>AT</div>
Today we may see the proof that EMagin would recover much slower from the latest slide as its shares went up 1.74% to Aehr Test's 3.9735%. As many rational traders are trying to avoid technology space, it makes sense to sum up Aehr Test Systems a little further and understand how it stands against EMagin and other similar entities. We are going to discuss some of the competitive aspects of both Aehr Test and EMagin.
Published over three weeks ago
View all stories for Aehr Test | View All Stories
Should we be buying EMagin or Aehr Test?
By analyzing existing basic indicators between Aehr Test and EMagin, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in EMagin with a short position in Aehr Test. Check out our pair correlation module for more information.

Let's begin by analyzing the assets. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aehr Test has an asset utilization ratio of 221.88 percent. This connotes that the company is making $2.22 for each dollar of assets. An increasing asset utilization means that Aehr Test Systems is more efficient with each dollar of assets it utilizes for everyday operations.

How important is Aehr Test's Liquidity

Aehr Test financial leverage refers to using borrowed capital as a funding source to finance Aehr Test Systems ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Aehr Test financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Aehr Test's total debt and its cash.

How Aehr Test utilizes its cash?

To perform a cash flow analysis of Aehr Test, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Aehr Test is receiving and how much cash it distributes out in a given period. The Aehr Test cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Aehr Test Net Cash Flow from Operations is relatively stable at the moment as compared to the past year. Aehr Test reported last year Net Cash Flow from Operations of (2.02 Million)

Breaking down Aehr Test Indicators

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Lets now take a look at Aehr Test revenue. Based on the latest financial disclosure, Aehr Test Systems reported 22.29 M of revenue. This is 99.45% lower than that of the Technology sector and 99.0% lower than that of the Semiconductor Equipment & Materials industry. The revenue for all United States stocks is 99.76% higher than that of the firm. As for EMagin we see revenue of 29.68 M, which is 98.67% lower than that of the Semiconductor Equipment & Materials

Sector
2.2 B
AEHR22.29 Million0.97
Sector2.24 Billion97.73
EMAN29.68 Million1.29

Another 3 percent spike for Aehr Test

The standard deviation is down to 5.46 as of today. As of the 24th of September, Aehr Test shows the mean deviation of 3.26, and Risk Adjusted Performance of (0.046028). Aehr Test Systems technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Aehr Test Systems, which can be compared to its rivals. Please confirm Aehr Test Systems variance, as well as the relationship between the value at risk and skewness to decide if Aehr Test Systems is priced correctly, providing market reflects its regular price of 1.57 per share. Please also double-check Aehr Test Systems total risk alpha, which is currently at (0.45) to validate the company can sustain itself at a future point.

Our Bottom Line On Aehr Test Systems

While some companies in the semiconductor equipment & materials industry are either recovering or due for a correction, Aehr Test may not be as strong as the others in terms of longer-term growth potentials. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither take in new shares of Aehr Test nor drop your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Aehr Test.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Aehr Test Systems. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com